John Oyler
Director, Chief Executive Officer · 11 filings · Latest: Aug 10, 2026
BeOne Medicines Ltd.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ONC | JOHN OYLER | — | Mar 10, 2025 | Proposed Sale | $242.67 | 41,210 | $10.0M | — | |
ONC | JOHN OYLER | — | Mar 7, 2025 | Proposed Sale | $249.13 | 58,590 | $14.6M | — | |
ONC | JOHN OYLER | — | Mar 6, 2025 | Proposed Sale | $259.15 | 40,109 | $10.4M | — | |
ONC | JOHN OYLER | — | Mar 3, 2025 | Proposed Sale | $244.30 | 101,000 | $24.7M | — | |
ONC | PAN-OYLER FOUNDATION | — | Nov 25, 2024 | Proposed Sale | $190.51 | 1,969 | $375.1K | — | |
ONC | JOHN F OYLER | — | Oct 8, 2024 | Proposed Sale | $243.02 | 6,175 | $1.5M | — | |
ONC | OYLER INVESTMENT LLC | — | Oct 8, 2024 | Proposed Sale | $243.02 | 10,000 | $2.4M | — | |
ONC | PAN-OYLER FOUNDATION | — | Aug 27, 2024 | Proposed Sale | $199.22 | 1,883 | $375.1K | — |
← Previous
Page 3 of 3